|
1
|
Morioka Y, Teshigawara K, Tomono Y, Wang
D, Izushi Y, Wake H, Liu K, Takahashi HK, Mori S and Nishibori M:
The specific localization of advanced glycation end-products (AGEs)
in rat pancreatic islets. J Pharmacol Sci. 134:218–224.
2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Miroliaei M, Aminjafari A, Ślusarczyk S,
Nawrot-Hadzik I, Rahimmalek M and Matkowski A: Inhibition of
glycation-induced cytotoxicity, protein glycation, and activity of
proteolytic enzymes by extract from Perovskia atriplicifolia
roots. Pharmacogn Mag. 13 (Suppl 3):S676–S683. 2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Loske C, Neumann A, Cunningham AM, Nichol
K, Schinzel R, Riederer P and Münch G: Cytotoxicity of advanced
glycation endproducts is mediated by oxidative stress. J Neural
Transm (Vienna). 105:1005–1015. 1998.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Gkogkolou P and Böhm M: Advanced glycation
end products: Keyplayers in skin aging? Dermatoendocrinol.
4:259–270. 2012.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Boyanova M and Huppertz B: Cytotoxic
effect of advanced glycation end products. Biotechnol Biotechnol
Equip. 23:1072–1078. 2009.
|
|
6
|
Wu B, Yu L, Hu P, Lu Y, Li J, Wei Y and He
R: GRP78 protects CHO cells from ribosylation. Biochim Biophys Acta
Mol Cell Res. 1865:629–637. 2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Stinghen AE, Massy ZA, Vlassara H, Striker
GE and Boullier A: Uremic toxicity of advanced glycation end
products in CKD. J Am Soc Nephrol. 27:354–370. 2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Sergi D, Boulestin H, Campbell FM and
Williams LM: The role of dietary advanced glycation end products in
metabolic dysfunction. Mol Nutr Food Res.
65(e1900934)2021.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Ali Khan MW, Banga K and Ali W:
Gluco-oxidation of proteins in etiology of diabetic retinopathy.
In: Diabetic retinopathy. InTech, 2012.
|
|
10
|
Chen JH, Lin X, Bu C and Zhang X: Role of
advanced glycation end products in mobility and considerations in
possible dietary and nutritional intervention strategies. Nutr
Metab (Lond). 15(72)2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Perrone A, Giovino A, Benny J and
Martinelli F: Advanced glycation end products (AGEs): Biochemistry,
signaling, analytical methods, and epigenetic effects. Oxid Med
Cell Longev. 2020(3818196)2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Takeuchi M and Yamagishi S: TAGE (toxic
AGEs) hypothesis in various chronic diseases. Med Hypotheses.
63:449–452. 2004.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Sato T, Shimogaito N, Wu X, Kikuchi S,
Yamagishi S and Takeuchi M: Toxic advanced glycation end products
(TAGE) theory in Alzheimer's disease. Am J Alzheimers Dis Other
Demen. 21:197–208. 2006.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Ashraf JM, Ahmad S, Choi I, Ahmad N,
Farhan M, Tatyana G and Shahab U: Recent advances in detection of
AGEs: Immunochemical, bioanalytical and biochemical approaches.
IUBMB Life. 67:897–913. 2015.PubMed/NCBI View
Article : Google Scholar
|
|
15
|
Federico G, Gori M, Randazzo E and
Vierucci F: Skin advanced glycation end-products evaluation in
infants according to the type of feeding and mother's smoking
habits. SAGE Open Med. 4(2050312116682126)2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Sellier C, Boulanger E, Maladry F, Tessier
FJ, Lorenzi R, Nevière R, Desreumaux P, Beuscart JB, Puisieux F and
Grossin N: Acrylamide induces accelerated endothelial aging in a
human cell model. Food Chem Toxicol. 83:140–145. 2015.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Palanissami G and Paul SFD: RAGE and its
ligands: Molecular interplay between glycation, inflammation, and
hallmarks of cancer-a review. Horm Cancer. 9:295–325.
2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Schröter D and Höhn A: Role of advanced
glycation end products in carcinogenesis and their therapeutic
implications. Curr Pharm Des. 24:5245–5251. 2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
ALjahdali N and Carbonero F: Impact of
maillard reaction products on nutrition and health: Current
knowledge and need to understand their fate in the human digestive
system. Crit Rev Food Sci Nutr. 59:474–487. 2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Cho HJ, Xie C and Cai H: AGE-induced
neuronal cell death is enhanced in G2019S LRRK2 mutation with
increased RAGE expression. Transl Neurodegener. 7(1)2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Takeuchi M, Sakasai-Sakai A, Takata T,
Ueda T, Takino J, Tsutsumi M, Hyogo H and Yamagishi S: Serum levels
of toxic AGEs (TAGE) may be a promising novel biomarker in
development and progression of NASH. Med Hypotheses. 84:490–493.
2015.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Takeuchi M and Yamagishi S: Involvement of
Toxic AGEs (TAGE) in the pathogenesis of diabetic vascular
complications and Alzheimer's disease. J Alzheimers Dis.
16:845–858. 2009.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Sakasai-Sakai A, Takata T, Takino J and
Takeuchi M: Impact of intracellular glyceraldehyde-derived advanced
glycation end-products on human hepatocyte cell death. Sci Rep.
7(14282)2017.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Liu X, Zheng L, Zhang R, Liu G, Xiao S,
Qiao X, Wu Y and Gong Z: Toxicological evaluation of advanced
glycation end product Nε-(carboxymethyl)lysine: Acute and subacute
oral toxicity studies. Regul Toxicol Pharmacol. 77:65–74.
2016.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Chou SM, Wang HS, Taniguchi A and Bucala
R: Advanced glycation endproducts in neurofilament conglomeration
of motoneurons in familial and sporadic amyotrophic lateral
sclerosis. Mol Med. 4:324–332. 1998.PubMed/NCBI
|
|
26
|
Bassi AM, Ledda S, Valentini S, De Pascale
MC, Rossi S, Odetti P and Cottalasso D: Damaging effects of
advanced glycation end-products in the murine macrophage cell line
J774A.1. Toxicol In Vitro. 16:339–347. 2002.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Chowdhury AA, Gawali NB, Bulani VD,
Kothavade PS, Mestry SN, Deshpande PS and Juvekar AR: In vitro
antiglycating effect and in vivo neuroprotective activity of
Trigonelline in d-galactose induced cognitive impairment. Pharmacol
Rep. 70:372–377. 2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Sampath C, Zhu Y, Sang S and Ahmedna M:
Bioactive compounds isolated from apple, tea, and ginger protect
against dicarbonyl induced stress in cultured human retinal
epithelial cells. Phytomedicine. 23:200–213. 2016.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Kim JH, Kim KA, Shin YJ, Kim H, Majid A
and Bae ON: Methylglyoxal induced advanced glycation end products
(AGE)/receptor for AGE (RAGE)-mediated angiogenic impairment in
bone marrow-derived endothelial progenitor cells. J Toxicol Environ
Health A. 81:266–277. 2018.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Takeuchi M, Takino JI, Sakasai-Sakai A,
Takata T and Tsutsumi M: Toxic AGE (TAGE) theory for the
pathophysiology of the Onset/Progression of NAFLD and ALD.
Nutrients. 9(634)2017.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Takeuchi M, Sato T, Takino J, Kobayashi Y,
Furuno S, Kikuchi S and Yamagishi S: Diagnostic utility of serum or
cerebrospinal fluid levels of toxic advanced glycation end-products
(TAGE) in early detection of Alzheimer's disease. Med Hypotheses.
69:1358–1366. 2007.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Azizian-Farsani F, Abedpoor N, Hasan
Sheikhha M, Gure AO, Nasr-Esfahani MH and Ghaedi K: Receptor for
advanced glycation end products acts as a fuel to colorectal cancer
development. Front Oncol. 10(552283)2020.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Swami P, Thiyagarajan S, Vidger A,
Indurthi VSK, Vetter SW and Leclerc E: Rage up-regulation
differently affects cell proliferation and migration in pancreatic
cancer cells. Int J Mol Sci. 21(7723)2020.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Akkus G, Izol V, Ok F, Evran M, Inceman M,
Erdogan S, Kaplan HM, Sert M and Tetiker T: Possible role of the
receptor of advanced glycation end products (RAGE) in the clinical
course of prostate neoplasia in patients with and without type 2
diabetes mellitus. Int J Clin Pract: Sep 21, 2020 (Epub ahead of
print). doi: 10.1111/ijcp.13723.
|
|
35
|
Chen MC, Chen KC, Chang GC, Lin H, Wu CC,
Kao WH, Teng CJ, Hsu SL and Yang TY: RAGE acts as an oncogenic role
and promotes the metastasis of human lung cancer. Cell Death Dis.
11(265)2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Zhang W, Deng X, Tang R and Wang H:
Receptor for advanced glycation end-product rs1800624 polymorphism
contributes to increase breast cancer risk: Evidence from a
meta-analysis. Medicine (Baltimore). 99(e22775)2020.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Takata T, Ueda T, Sakasai-Sakai A and
Takeuchi M: Generation of glyceraldehyde-derived advanced glycation
end-products in pancreatic cancer cells and the potential of tumor
promotion. World J Gastroenterol. 23:4910–4919. 2017.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Waqas K, Chen J, van der Eerden BCJ, Ikram
MA, Uitterlinden AG, Voortman T and Zillikens M: Dietary advanced
glycation end-products (dAGEs) intake and bone health: A
cross-sectional analysis in the rotterdam study. Nutrients.
12(2377)2020.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Yamagishi S and Matsui T: Role of ligands
of receptor for advanced glycation end products (RAGE) in
peripheral artery disease. Rejuvenation Res. 21:456–463.
2018.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Tessier FJ, Boulanger E and Howsam M:
Metabolic transit of dietary advanced glycation end-products-the
case of NƐ-carboxymethyllysine. Glycoconj J: Sep 29,
2020 (Epub ahead of print). doi: 10.1007/s10719-020-09950-y.
|
|
41
|
Takeuchi M: Serum levels of toxic AGEs
(TAGE) may be a promising novel biomarker for the onset/progression
of lifestyle-related diseases. Diagnostics (Basel).
6(23)2016.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Kuzan A, Chwiłkowska A, Kobielarz M,
Pezowicz C and Gamian A: Glycation of extracellular matrix proteins
and its role in atherosclerosis. Postepy Hig Med Dosw (Online).
66:804–809. 2012.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Kuzan A, Chwiłkowska A, Maksymowicz K,
Bronowicka-Szydełko A, Stach K, Pezowicz C and Gamian A: Advanced
glycation end products as a source of artifacts in immunoenzymatic
methods. Glycoconj J. 35:95–103. 2018.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Humeny A, Kislinger T, Becker CM and
Pischetsrieder M: Qualitative determination of specific protein
glycation products by matrix-assisted laser desorption/ionization
mass spectrometry Peptide mapping. J Agric Food Chem. 50:2153–2160.
2002.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Yamagishi S and Matsui T: Role of
Hyperglycemia-induced advanced glycation end product (AGE)
accumulation in atherosclerosis. Ann Vasc Dis. 11:253–258.
2018.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Kim Y, Keogh JB, Deo P and Clifton PM:
Differential effects of dietary patterns on advanced glycation end
products: A randomized crossover study. Nutrients.
12(1767)2020.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Münch G, Keis R, Wessels A, Riederer P,
Bahner U, Heidland A, Niwa T, Lemke HD and Schinzel R:
Determination of advanced glycation end products in serum by
fluorescence spectroscopy and competitive ELISA. Eur J Clin Chem
Clin Biochem. 35:669–677. 1997.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Kuzan A, Michel O and Gamian A: Glycation
of matrix proteins in the artery inhibits migration of smooth
muscle cells from the media to the intima. Folia Biol (Praha).
63:105–114. 2017.PubMed/NCBI
|
|
49
|
Younus H and Anwar S: Prevention of
Non-enzymatic glycosylation (Glycation): Implication in the
treatment of diabetic complication. Int J Health Sci (Qassim).
10:261–277. 2016.PubMed/NCBI
|
|
50
|
Hashemzaei M, Tabrizian K, Alizadeh Z,
Pasandideh S, Rezaee R, Mamoulakis C, Tsatsakis A, Skaperda Z,
Kouretas D and Shahraki J: Resveratrol, curcumin and gallic acid
attenuate glyoxal-induced damage to rat renal cells. Toxicol Rep.
7:1571–1577. 2020.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Schalkwijk CG and Stehouwer CDA:
Methylglyoxal, a highly reactive dicarbonyl compound, in diabetes,
its vascular complications and other age-related diseases. Physiol
Rev. 100:407–461. 2020.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Byun K, Bayarsaikhan D, Bayarsaikhan E,
Son M, Oh S, Lee J, Son HI, Won MH, Kim SU, Song BJ and Lee B:
Microglial AGE-albumin is critical in promoting alcohol-induced
neurodegeneration in rats and humans. PLoS One.
9(e104699)2014.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Bayarsaikhan E, Bayarsaikhan D, Lee J, Son
M, Oh S, Moon J, Park HJ, Roshini A, Kim SU, Song BJ, et al:
Microglial AGE-albumin is critical for neuronal death in
Parkinson's disease: A possible implication for theranostics. Int J
Nanomedicine. 10:281–292. 2016.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Fleitas C, Piñol-Ripoll G, Marfull P,
Rocandio D, Ferrer I, Rampon C, Egea J and Espinet C: proBDNF is
modified by advanced glycation end products in Alzheimer's disease
and causes neuronal apoptosis by inducing p75 neurotrophin receptor
processing. Mol Brain. 11(68)2018.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Moldogazieva NT, Mokhosoev IM, Mel'nikova
TI, Porozov YB and Terentiev AA: Oxidative stress and advanced
lipoxidation and glycation end products (ALEs and AGEs) in aging
and age-related diseases. Oxid Med Cell Longev.
2019(3085756)2019.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Wang X, Chen XX, Yu HT, Tan Y, Lin Q,
Keller BB, Zheng Y and Cai L: Engineered cardiac tissues: A novel
in vitro model to investigate the pathophysiology of mouse diabetic
cardiomyopathy. Acta Pharmacol Sin: Oct 9, 2020 (Epub ahead of
print). doi: 10.1038/s41401-020-00538-8.
|
|
57
|
Wang WC, Lee JA and Chou CK: Open access
short review evolving evidence of methylglyoxal and dicarbonyl
stress related diseases from diabetic to non-diabetic models. Pharm
Anal Acta. 7(4)2016.
|
|
58
|
Takata T, Sakasai-Sakai A and Takeuchi M:
Impact of intracellular toxic advanced glycation end-products
(TAGE) on murine myoblast cell death. Diabetol Metab Syndr.
12(54)2020.PubMed/NCBI View Article : Google Scholar
|
